Accessibility navigation

Towards the use of hydrogels in the treatment of limbal stem cell deficiency


Downloads per month over past year

Wright, B., Mi, S. and Connon, C. J. (2013) Towards the use of hydrogels in the treatment of limbal stem cell deficiency. Drug Discovery Today, 18 (1-2). pp. 79-86. ISSN 1359-6446

Text - Accepted Version
· Please see our End User Agreement before downloading.


To link to this article DOI: 10.1016/j.drudis.2012.07.012


Corneal blindness caused by limbal stem cell deficiency (LSCD) is a prevailing disorder worldwide. Clinical outcomes for LSCD therapy using amniotic membrane (AM) are unpredictable. Hydrogels can eliminate limitations of standard therapy for LSCD, because they present all the advantages of AM (i.e. biocompatibility, inertness and a biodegradable structure) but unlike AM, they are structurally uniform and can be easily manipulated to alter mechanical and physical properties. Hydrogels can be delivered with minimum trauma to the ocular surface and do not require extensive serological screening before clinical application. The hydrogel structure is also amenable to modifications which direct stem cell fate. In this focussed review we highlight hydrogels as biomaterial substrates which may replace and/or complement AM in the treatment of LSCD.

Item Type:Article
Divisions:Faculty of Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Division of Pharmacology
ID Code:29237

Download Statistics for this item.

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation